Dexcom (DXCM) Accumulated Depreciation & Amortization (2016 - 2025)
Dexcom (DXCM) has disclosed Accumulated Depreciation & Amortization for 16 consecutive years, with $39.5 million as the latest value for Q4 2025.
- Quarterly Accumulated Depreciation & Amortization fell 1.0% to $39.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.5 million through Dec 2025, down 1.0% year-over-year, with the annual reading at $39.5 million for FY2025, 1.0% down from the prior year.
- Accumulated Depreciation & Amortization for Q4 2025 was $39.5 million at Dexcom, up from $28.1 million in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $466.3 million in Q3 2023, with the low at $9.2 million in Q1 2025.
- Average Accumulated Depreciation & Amortization over 5 years is $83.2 million, with a median of $40.8 million recorded in 2023.
- The sharpest move saw Accumulated Depreciation & Amortization surged 432.71% in 2023, then crashed 97.96% in 2024.
- Over 5 years, Accumulated Depreciation & Amortization stood at $102.0 million in 2021, then tumbled by 54.22% to $46.7 million in 2022, then dropped by 10.28% to $41.9 million in 2023, then decreased by 4.77% to $39.9 million in 2024, then fell by 1.0% to $39.5 million in 2025.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $39.5 million, $28.1 million, and $18.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.